Adiuvo Investments S.A. (WSE: ADV)
Poland
· Delayed Price · Currency is PLN
0.308
+0.007 (2.33%)
Sep 27, 2024, 4:31 PM CET
Adiuvo Investments Revenue
Adiuvo Investments had revenue of 305.00K PLN in the quarter ending March 31, 2024, a decrease of -793.18%. This brings the company's revenue in the last twelve months to 1.34M, up 5,256.00% year-over-year. In the year 2023, Adiuvo Investments had annual revenue of 990.00K with 472.25% growth.
Revenue (ttm)
1.34M
Revenue Growth
+5,256.00%
P/S Ratio
2.15
Revenue / Employee
267.80K
Employees
5
Market Cap
4.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 990.00K | 817.00K | 472.25% |
Dec 31, 2022 | 173.00K | -1.43M | -89.21% |
Dec 31, 2021 | 1.60M | 662.00K | 70.28% |
Dec 31, 2020 | 942.00K | -836.00K | -47.02% |
Dec 31, 2019 | 1.78M | -1.02M | -36.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.06B |
NEUCA S.A. | 12.13B |
Sopharma AD | 4.35B |
Synektik Spólka Akcyjna | 618.67M |
Celon Pharma S.A. | 206.81M |
Ryvu Therapeutics S.A. | 82.39M |
Voxel S.A. | 476.19M |
Selvita S.A. | 329.02M |